$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Has Regeneron Pharmaceuticals (REGN) Outpaced Other Medical Stocks This Year?
12:59pm, Wednesday, 15'th Sep 2021
Is (REGN) Outperforming Other Medical Stocks This Year?
7 Gene Editing Stocks Promising to Change our DNA
12:45pm, Wednesday, 15'th Sep 2021
Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market. The post 7 Gene Editing Stocks Promising to Change our DNA appeared
U.S. to pay $2.9 billion for an additional 1.4 million doses of Regeneron's COVID-19 therapy
07:40am, Wednesday, 15'th Sep 2021
Shares of Regeneron Pharmaceuticals Inc. REGN, +0.88% gained 2.1% in premarket trading on Wednesday, the day after the company said the U.S. government had purchased an additional 1.4 million doses of
TARRYTOWN, N.Y., Sept. 14, 2021 /PRNewswire/ -- New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million doses REGEN-COV currently authorized
Regeneron (REGN) Stock Sinks As Market Gains: What You Should Know
07:35pm, Monday, 13'th Sep 2021
In the latest trading session, Regeneron (REGN) closed at $639.52, marking a -1.69% move from the previous day.
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
Regeneron Announces Investor Conference Presentations
04:05pm, Wednesday, 08'th Sep 2021
TARRYTOWN, N.Y., Sept. 8, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Morgan Stanley 19th Annual Global Healthcare Conference
Bet on These 5 Low-Beta Stocks to Combat Market Volatility
12:30pm, Tuesday, 07'th Sep 2021
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. REGN, CAJ, COG, EXC & WMT are well poised to gain.
My Fat-Margin Stocks Returned 78% Last Year
10:46am, Tuesday, 07'th Sep 2021
It's been a great year for stocks with fat profit margins.
3 Large Biotech Stocks Worth Adding to Your Portfolio
12:10pm, Thursday, 02'nd Sep 2021
REGN, MRNA & VRTX are the three biotech companies that are likely to outperform the sector on the back of strong fundamentals.
Now May Be the Big Moment for These 2 COVID Stocks
06:00am, Thursday, 02'nd Sep 2021
Their products are seeing a surge in demand.
Antibody drugs take off in new Covid surge
03:23pm, Tuesday, 31'st Aug 2021
Meg Tirrell joins The Exchange with more information about Covid antibody treatments and the increasing demand for these drugs in places where the delta variant is surging. For access to live and excl
Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year?
12:56pm, Monday, 30'th Aug 2021
Is (REGN) Outperforming Other Medical Stocks This Year?
Sanofi (SNY)/Regeneron's Dupixent Meets Eczema Study Goal
12:10pm, Monday, 30'th Aug 2021
Sanofi (SNY) and Regeneron (REGN)'s Dupixent meet all primary and secondary endpoints in phase III study to treat children aged six months to five years with moderate-to-severe atopic dermatitis.
Coronavirus antibody drugs take off
10:49am, Monday, 30'th Aug 2021
CNBC's Meg Tirrell reports on the surge in Covid antibody drug orders.
Sign In
Buy REGN